Where It Comes From
2-Aminoanthraquinone has been produced industrially since the late 19th century as a key building block for anthraquinone-based dyes, particularly vat dyes used to color cotton, wool, and polyester fabrics. It is synthesized by nitrating anthraquinone followed by reduction, and for over a century it was considered an unremarkable industrial chemical. [1] That perception changed in 1978 when National Toxicology Program (NTP) studies found it caused hepatocellular carcinomas and other tumors in rodents in long-term feeding studies. The EPA subsequently classified it as a Group B2 probable human carcinogen. [2] Despite this classification, 2-aminoanthraquinone remained widely used in dye manufacturing in countries with less stringent chemical regulations. It is listed as a Hazardous Air Pollutant under the Clean Air Act and is reportable under the Toxics Release Inventory. Releases come primarily from dye manufacturing facilities, textile dyeing operations, and pigment production plants, where it can be discharged into wastewater or emitted as airborne particulate. The compound is relatively persistent in the environment due to its aromatic ring structure and low water solubility, and it has been detected in sediments near dye manufacturing sites. [3]
How You Are Exposed
Occupational exposure is the predominant route — workers in dye manufacturing, textile dyeing, and pigment production can inhale dusts or absorb the compound through skin contact. The orange-red powder has noticeable skin-staining properties that indicate dermal contact has occurred. Environmental exposure near industrial facilities may occur via contaminated water or soil. General population exposure is very low, mostly limited to trace residues in consumer dyed textiles, though skin absorption from wearing dyed clothing is considered negligible.
Why It Matters
The NTP bioassay found clear evidence of carcinogenicity in female mice and some evidence in rats, resulting in the Group B2 (probable human carcinogen) classification. [2] The carcinogenic mechanism is thought to involve metabolic activation of the aromatic amine group to reactive electrophilic intermediates that can form DNA adducts, similar to other arylamine carcinogens. Chronic skin and eye irritation occur with repeated occupational contact. Aquatic toxicity is a concern near manufacturing discharges, as the compound is moderately toxic to aquatic organisms.
Who Is at Risk
Workers in dye synthesis facilities and textile dyeing plants, particularly in countries with high textile manufacturing output (India, China, Bangladesh), face the highest exposure risk. Laboratory chemists handling it as a reagent or standard are also at risk without proper controls. The general public has negligible exposure unless living immediately adjacent to a discharge-impacted waterway.
How to Lower Your Exposure
1. Dye industry workers should use engineering controls (enclosed processes, local exhaust ventilation) and wear NIOSH-approved respirators for dust, plus chemical-resistant gloves and protective clothing. 2. Facilities should monitor air levels and conduct regular biological monitoring of workers. 3. If you work with this compound in a laboratory, handle it in a fume hood and treat all contaminated materials as hazardous waste. 4. Advocate for substitution with safer dye intermediates where feasible.
References
- [1][1] Kirk-Othmer Encyclopedia of Chemical Technology. Anthraquinone Dyes. John Wiley & Sons.
- [2][2] US EPA IRIS. 2-Aminoanthraquinone (CASRN 117-79-3). https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0230_summary.pdf
- [3][3] NTP Technical Report 360 (1989). Toxicology and Carcinogenesis Studies of 2-Aminoanthraquinone. National Toxicology Program. https://ntp.niehs.nih.gov/publications/reports/tr/300s/tr360
Recovery & Clinical Information
Body Half-Life
No well-established human pharmacokinetic data exists for 2-aminoanthraquinone. By analogy with other aromatic amines, hepatic metabolism via N-acetylation and N-hydroxylation pathways would be expected, with urinary excretion of conjugated metabolites over days to weeks. The anthraquinone ring structure may slow metabolism compared to simpler arylamines.
Testing & Biomarkers
There is no standard clinical biomarker test for 2-aminoanthraquinone. Research laboratories can measure it in urine or plasma by HPLC or LC-MS/MS. Hemoglobin adducts (analogous to those measured for other aromatic amines) could serve as a retrospective exposure marker but are not offered by routine clinical labs. Report occupational exposures to an occupational medicine physician for appropriate monitoring.
Interventions
Remove the source of exposure. For skin contact, wash thoroughly with soap and water. For high-level inhalation, seek fresh air and medical evaluation. No specific antidote exists. Long-term cancer surveillance for heavily exposed workers should include periodic evaluation as advised by an occupational physician. Liver function monitoring may be warranted given animal evidence of hepatotoxicity.
Recovery Timeline
Acute skin and respiratory irritation resolves within hours to days after exposure ends. For cancer risk from past exposure, there is no timeline for risk elimination; the excess risk is carried forward but does not increase after exposure ceases. Regular occupational health monitoring is the appropriate long-term strategy.
Recovery References
- [1]NTP Technical Report 360 (1989). 2-Aminoanthraquinone. https://ntp.niehs.nih.gov/publications/reports/tr/300s/tr360
- [2]IARC Monographs Vol. 48 (1990). Some Flame Retardants and Textile Chemicals. 2-Aminoanthraquinone, pp. 307–318.